# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-105475
Filing Date
2025-08-08
Accepted
2025-08-08 07:45:48
Documents
61
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | hrtx-20250630.htm iXBRL | 10-Q | 2218081
2 | EX-10.1 | hrtx-ex10_1.htm | EX-10.1 | 34803
3 | EX-10.2 | hrtx-ex10_2.htm | EX-10.2 | 22055
4 | EX-10.3 | hrtx-ex10_3.htm | EX-10.3 | 83966
5 | EX-10.4 | hrtx-ex10_4.htm | EX-10.4 | 18618
6 | EX-31.1 | hrtx-ex31_1.htm | EX-31.1 | 17258
7 | EX-31.2 | hrtx-ex31_2.htm | EX-31.2 | 17038
8 | EX-32.1 | hrtx-ex32_1.htm | EX-32.1 | 19223
| Complete submission text file | 0000950170-25-105475.txt |  | 9934990

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | hrtx-20250630.xsd | EX-101.SCH | 996691
64 | EXTRACTED XBRL INSTANCE DOCUMENT | hrtx-20250630_htm.xml | XML | 2230258

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 251196219
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)